During the past decade, Erlanger Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Erlanger Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator, "American College of Surgeons" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Eastern Cooperative Oncology Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Erlanger Cancer Center" are "Bladder Cancer" (1 trials), "Breast Cancer" (1 trials), "Pancreatic Cancer" (1 trials), "Prostate Cancer" (1 trials) and "Transitional Cell Cancer of the Renal Pelvis and Ureter" (1 trials). Many other conditions were trialed in "Erlanger Cancer Center" in a lesser frequency.

Most popular intervention types in "Erlanger Cancer Center" are "Drug" (4 trials), "Radiation" (2 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "gemcitabine hydrochloride" (2 trials), "Radiation Therapy" (1 trials), "adjuvant therapy" (1 trials), "anastrozole" (1 trials) and "bicalutamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Erlanger Cancer Center" are 2 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Erlanger Cancer Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Erlanger Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Erlanger Cancer Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".